This study was supported by an unrestricted grant from Boehringer Mannheim, Mannheim, Germany. Effect of Beta-Blocker Therapy in Patients With Coronary Artery Disease in New York Heart Association Classes II and III-subgroup findings from randomized trials in postinfarction patients Academic Article uri icon